Concepts (254)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| General Surgery | 16 | 2025 | 191 | 3.470 |
Why?
|
| Internship and Residency | 19 | 2025 | 736 | 2.980 |
Why?
|
| Rectal Neoplasms | 7 | 2022 | 98 | 2.970 |
Why?
|
| Colorectal Neoplasms | 9 | 2022 | 263 | 2.660 |
Why?
|
| Colectomy | 7 | 2025 | 104 | 2.600 |
Why?
|
| Postoperative Complications | 16 | 2025 | 1184 | 2.360 |
Why?
|
| Surgeons | 8 | 2023 | 159 | 2.150 |
Why?
|
| Colorectal Surgery | 5 | 2025 | 53 | 1.680 |
Why?
|
| Time-to-Treatment | 4 | 2021 | 98 | 1.680 |
Why?
|
| Fellowships and Scholarships | 5 | 2025 | 96 | 1.630 |
Why?
|
| Hospitals, High-Volume | 5 | 2021 | 32 | 1.540 |
Why?
|
| Faculty, Medical | 3 | 2018 | 192 | 1.470 |
Why?
|
| Colonic Neoplasms | 3 | 2023 | 215 | 1.400 |
Why?
|
| Career Mobility | 3 | 2018 | 62 | 1.220 |
Why?
|
| Education, Medical, Graduate | 12 | 2025 | 313 | 1.220 |
Why?
|
| Personnel Selection | 3 | 2025 | 50 | 1.160 |
Why?
|
| New York | 11 | 2020 | 133 | 1.160 |
Why?
|
| Gallbladder Diseases | 3 | 2016 | 26 | 1.120 |
Why?
|
| Mobile Applications | 3 | 2017 | 129 | 1.100 |
Why?
|
| Minority Groups | 3 | 2023 | 135 | 1.100 |
Why?
|
| Cholecystectomy, Laparoscopic | 3 | 2016 | 46 | 1.090 |
Why?
|
| Quality Improvement | 5 | 2025 | 413 | 1.050 |
Why?
|
| Patient Readmission | 5 | 2025 | 420 | 1.040 |
Why?
|
| Surgical Stapling | 2 | 2024 | 11 | 1.040 |
Why?
|
| Male | 47 | 2025 | 27623 | 1.000 |
Why?
|
| Anastomosis, Surgical | 2 | 2024 | 103 | 0.990 |
Why?
|
| Robotic Surgical Procedures | 4 | 2021 | 110 | 0.970 |
Why?
|
| Correspondence as Topic | 1 | 2025 | 10 | 0.950 |
Why?
|
| Rectum | 4 | 2024 | 86 | 0.920 |
Why?
|
| Incisional Hernia | 1 | 2024 | 11 | 0.920 |
Why?
|
| Humans | 65 | 2025 | 59106 | 0.920 |
Why?
|
| Ileostomy | 3 | 2022 | 25 | 0.900 |
Why?
|
| Stress, Psychological | 2 | 2018 | 442 | 0.880 |
Why?
|
| Female | 47 | 2025 | 30613 | 0.880 |
Why?
|
| Patient Discharge | 3 | 2025 | 485 | 0.880 |
Why?
|
| Middle Aged | 31 | 2025 | 16240 | 0.830 |
Why?
|
| Lymphoma | 1 | 2023 | 99 | 0.810 |
Why?
|
| Attitude of Health Personnel | 4 | 2021 | 548 | 0.810 |
Why?
|
| Retrospective Studies | 21 | 2025 | 6030 | 0.800 |
Why?
|
| Laparoscopy | 8 | 2024 | 396 | 0.800 |
Why?
|
| Schools, Medical | 3 | 2018 | 140 | 0.790 |
Why?
|
| Adenocarcinoma | 2 | 2021 | 322 | 0.770 |
Why?
|
| Travel | 2 | 2021 | 37 | 0.760 |
Why?
|
| Personnel Turnover | 2 | 2018 | 20 | 0.760 |
Why?
|
| Transanal Endoscopic Surgery | 1 | 2021 | 23 | 0.750 |
Why?
|
| Obesity, Morbid | 3 | 2018 | 91 | 0.740 |
Why?
|
| Intestinal Obstruction | 2 | 2020 | 49 | 0.710 |
Why?
|
| Aged | 26 | 2025 | 13348 | 0.690 |
Why?
|
| Postoperative Period | 2 | 2017 | 127 | 0.680 |
Why?
|
| Career Choice | 5 | 2025 | 114 | 0.670 |
Why?
|
| Adult | 27 | 2025 | 15615 | 0.670 |
Why?
|
| Quality of Health Care | 2 | 2021 | 510 | 0.660 |
Why?
|
| Surveys and Questionnaires | 8 | 2021 | 2509 | 0.650 |
Why?
|
| Specialties, Surgical | 2 | 2016 | 45 | 0.650 |
Why?
|
| Health Services Accessibility | 2 | 2021 | 521 | 0.640 |
Why?
|
| Motivation | 2 | 2018 | 273 | 0.630 |
Why?
|
| Intraoperative Complications | 2 | 2018 | 82 | 0.610 |
Why?
|
| Gastrointestinal Agents | 1 | 2018 | 25 | 0.600 |
Why?
|
| Infliximab | 1 | 2018 | 49 | 0.600 |
Why?
|
| Follow-Up Studies | 10 | 2024 | 2330 | 0.580 |
Why?
|
| United States | 18 | 2025 | 7370 | 0.580 |
Why?
|
| Colitis, Ulcerative | 1 | 2018 | 71 | 0.570 |
Why?
|
| Time Out, Healthcare | 1 | 2017 | 1 | 0.570 |
Why?
|
| Physician's Role | 1 | 2018 | 120 | 0.560 |
Why?
|
| Treatment Outcome | 13 | 2024 | 5227 | 0.560 |
Why?
|
| Clinical Competence | 9 | 2025 | 679 | 0.560 |
Why?
|
| Confidentiality | 1 | 2017 | 51 | 0.550 |
Why?
|
| Colostomy | 1 | 2017 | 23 | 0.550 |
Why?
|
| Biological Products | 1 | 2018 | 90 | 0.550 |
Why?
|
| Electrodes, Implanted | 1 | 2017 | 37 | 0.540 |
Why?
|
| Electric Stimulation Therapy | 1 | 2017 | 27 | 0.540 |
Why?
|
| Hepatectomy | 1 | 2017 | 60 | 0.540 |
Why?
|
| Fecal Incontinence | 1 | 2017 | 28 | 0.540 |
Why?
|
| Surgery Department, Hospital | 1 | 2016 | 20 | 0.540 |
Why?
|
| Racism | 1 | 2018 | 81 | 0.540 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2018 | 297 | 0.530 |
Why?
|
| Cultural Diversity | 1 | 2017 | 51 | 0.530 |
Why?
|
| Adaptation, Psychological | 1 | 2018 | 259 | 0.530 |
Why?
|
| Teaching Rounds | 1 | 2016 | 11 | 0.520 |
Why?
|
| Physicians, Women | 1 | 2016 | 35 | 0.520 |
Why?
|
| Digestive System Surgical Procedures | 4 | 2017 | 87 | 0.490 |
Why?
|
| Time Factors | 6 | 2025 | 3586 | 0.490 |
Why?
|
| Telemedicine | 2 | 2017 | 307 | 0.490 |
Why?
|
| Self Care | 1 | 2017 | 207 | 0.490 |
Why?
|
| Practice Patterns, Physicians' | 3 | 2022 | 683 | 0.490 |
Why?
|
| Leadership | 1 | 2017 | 193 | 0.480 |
Why?
|
| Patient Participation | 1 | 2017 | 216 | 0.480 |
Why?
|
| Palliative Care | 1 | 2017 | 215 | 0.470 |
Why?
|
| Operating Rooms | 1 | 2015 | 55 | 0.470 |
Why?
|
| Stents | 2 | 2020 | 454 | 0.460 |
Why?
|
| Students, Medical | 1 | 2017 | 244 | 0.460 |
Why?
|
| Neoplasm Staging | 5 | 2023 | 445 | 0.450 |
Why?
|
| Liver Neoplasms | 1 | 2017 | 277 | 0.450 |
Why?
|
| Patient Satisfaction | 1 | 2017 | 411 | 0.440 |
Why?
|
| Risk Assessment | 2 | 2016 | 1898 | 0.420 |
Why?
|
| Computer Simulation | 1 | 2015 | 457 | 0.400 |
Why?
|
| Patient Care Team | 1 | 2015 | 325 | 0.400 |
Why?
|
| Colon | 3 | 2024 | 135 | 0.390 |
Why?
|
| Qualitative Research | 3 | 2025 | 618 | 0.390 |
Why?
|
| Gastrectomy | 3 | 2018 | 37 | 0.390 |
Why?
|
| Logistic Models | 6 | 2021 | 1223 | 0.380 |
Why?
|
| Combined Modality Therapy | 3 | 2021 | 353 | 0.360 |
Why?
|
| Disease-Free Survival | 2 | 2021 | 228 | 0.350 |
Why?
|
| Anastomotic Leak | 2 | 2024 | 33 | 0.340 |
Why?
|
| Hospitalization | 2 | 2016 | 1288 | 0.340 |
Why?
|
| Length of Stay | 3 | 2025 | 769 | 0.320 |
Why?
|
| Grounded Theory | 2 | 2018 | 17 | 0.300 |
Why?
|
| Hospital Mortality | 4 | 2017 | 836 | 0.290 |
Why?
|
| Aged, 80 and over | 11 | 2020 | 5101 | 0.290 |
Why?
|
| Elective Surgical Procedures | 2 | 2025 | 109 | 0.290 |
Why?
|
| Cohort Studies | 4 | 2018 | 2367 | 0.280 |
Why?
|
| Databases, Factual | 4 | 2018 | 805 | 0.280 |
Why?
|
| Prospective Studies | 6 | 2022 | 3052 | 0.270 |
Why?
|
| Reoperation | 2 | 2018 | 270 | 0.270 |
Why?
|
| Propensity Score | 2 | 2025 | 144 | 0.260 |
Why?
|
| Minimally Invasive Surgical Procedures | 2 | 2024 | 93 | 0.250 |
Why?
|
| Social Support | 2 | 2018 | 355 | 0.250 |
Why?
|
| Diverticulitis, Colonic | 1 | 2024 | 32 | 0.230 |
Why?
|
| Risk Factors | 5 | 2024 | 4948 | 0.230 |
Why?
|
| Endocrine Surgical Procedures | 1 | 2023 | 1 | 0.220 |
Why?
|
| Academic Medical Centers | 4 | 2023 | 305 | 0.210 |
Why?
|
| Lymph Node Excision | 1 | 2023 | 36 | 0.210 |
Why?
|
| Age Factors | 5 | 2018 | 1499 | 0.210 |
Why?
|
| Prognosis | 3 | 2023 | 1593 | 0.200 |
Why?
|
| School Admission Criteria | 1 | 2022 | 8 | 0.200 |
Why?
|
| Lymph Nodes | 1 | 2023 | 214 | 0.200 |
Why?
|
| Young Adult | 9 | 2019 | 4250 | 0.200 |
Why?
|
| Academic Failure | 2 | 2018 | 2 | 0.190 |
Why?
|
| Radiotherapy, Intensity-Modulated | 2 | 2011 | 31 | 0.190 |
Why?
|
| Aging | 2 | 2018 | 710 | 0.180 |
Why?
|
| Colonoscopy | 1 | 2021 | 86 | 0.180 |
Why?
|
| Gastric Bypass | 2 | 2018 | 74 | 0.170 |
Why?
|
| Linear Models | 2 | 2018 | 400 | 0.170 |
Why?
|
| Weight Loss | 3 | 2018 | 263 | 0.170 |
Why?
|
| Educational Measurement | 2 | 2018 | 210 | 0.170 |
Why?
|
| Hospitals, Low-Volume | 2 | 2016 | 17 | 0.160 |
Why?
|
| Massachusetts | 1 | 2025 | 2004 | 0.160 |
Why?
|
| Regional Health Planning | 1 | 2019 | 11 | 0.160 |
Why?
|
| Models, Statistical | 2 | 2017 | 298 | 0.160 |
Why?
|
| Quality of Life | 4 | 2020 | 1134 | 0.150 |
Why?
|
| Life Change Events | 1 | 2018 | 65 | 0.150 |
Why?
|
| Perioperative Period | 1 | 2018 | 19 | 0.150 |
Why?
|
| Appendectomy | 1 | 2018 | 49 | 0.150 |
Why?
|
| Hormone Replacement Therapy | 1 | 2018 | 28 | 0.140 |
Why?
|
| Health Care Surveys | 1 | 2019 | 270 | 0.140 |
Why?
|
| Video-Assisted Surgery | 1 | 2017 | 10 | 0.140 |
Why?
|
| Carcinoma, Signet Ring Cell | 1 | 2017 | 6 | 0.140 |
Why?
|
| Computer Security | 1 | 2017 | 12 | 0.140 |
Why?
|
| Appendicitis | 1 | 2018 | 74 | 0.140 |
Why?
|
| Fees and Charges | 1 | 2017 | 18 | 0.140 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2017 | 30 | 0.140 |
Why?
|
| Biliopancreatic Diversion | 1 | 2017 | 2 | 0.140 |
Why?
|
| Standard of Care | 1 | 2017 | 27 | 0.140 |
Why?
|
| Duodenum | 1 | 2017 | 42 | 0.140 |
Why?
|
| Observer Variation | 1 | 2017 | 205 | 0.140 |
Why?
|
| Feasibility Studies | 2 | 2017 | 520 | 0.130 |
Why?
|
| Emergencies | 1 | 2017 | 111 | 0.130 |
Why?
|
| Patient Outcome Assessment | 1 | 2016 | 52 | 0.130 |
Why?
|
| Device Removal | 1 | 2017 | 61 | 0.130 |
Why?
|
| Morbidity | 1 | 2016 | 110 | 0.130 |
Why?
|
| Hyperlipidemias | 1 | 2016 | 34 | 0.130 |
Why?
|
| Interviews as Topic | 1 | 2018 | 481 | 0.130 |
Why?
|
| Income | 1 | 2017 | 156 | 0.130 |
Why?
|
| Comorbidity | 2 | 2017 | 1077 | 0.130 |
Why?
|
| Incidence | 4 | 2024 | 1226 | 0.130 |
Why?
|
| Pandemics | 1 | 2021 | 613 | 0.130 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2016 | 64 | 0.130 |
Why?
|
| Hospitals, University | 1 | 2016 | 52 | 0.130 |
Why?
|
| Educational Status | 1 | 2017 | 264 | 0.130 |
Why?
|
| Interdisciplinary Communication | 1 | 2016 | 103 | 0.130 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2016 | 31 | 0.130 |
Why?
|
| Sex Distribution | 1 | 2016 | 242 | 0.130 |
Why?
|
| Opioid-Related Disorders | 1 | 2022 | 456 | 0.130 |
Why?
|
| Anal Canal | 1 | 2016 | 34 | 0.130 |
Why?
|
| Adolescent | 5 | 2019 | 5816 | 0.120 |
Why?
|
| Urinary Tract Infections | 1 | 2016 | 79 | 0.120 |
Why?
|
| Surgical Wound Infection | 1 | 2016 | 110 | 0.120 |
Why?
|
| Anxiety | 1 | 2018 | 387 | 0.120 |
Why?
|
| Socioeconomic Factors | 1 | 2017 | 741 | 0.120 |
Why?
|
| Delivery of Health Care | 1 | 2019 | 407 | 0.120 |
Why?
|
| Operative Time | 1 | 2014 | 74 | 0.120 |
Why?
|
| Esophageal Achalasia | 1 | 2015 | 28 | 0.120 |
Why?
|
| Esophagus | 1 | 2014 | 50 | 0.120 |
Why?
|
| Cholecystitis, Acute | 1 | 2014 | 29 | 0.120 |
Why?
|
| Societies, Medical | 1 | 2016 | 332 | 0.120 |
Why?
|
| Sex Factors | 1 | 2017 | 934 | 0.110 |
Why?
|
| Stomach Neoplasms | 1 | 2014 | 69 | 0.110 |
Why?
|
| Patient Safety | 1 | 2016 | 237 | 0.110 |
Why?
|
| Acute Disease | 1 | 2014 | 656 | 0.100 |
Why?
|
| Risk Adjustment | 1 | 2012 | 93 | 0.100 |
Why?
|
| Paranasal Sinus Neoplasms | 1 | 2011 | 5 | 0.100 |
Why?
|
| Nose Neoplasms | 1 | 2011 | 17 | 0.090 |
Why?
|
| Global Health | 1 | 2012 | 167 | 0.090 |
Why?
|
| Radiotherapy | 1 | 2011 | 62 | 0.090 |
Why?
|
| Hypertension | 1 | 2016 | 567 | 0.090 |
Why?
|
| Radiosurgery | 1 | 2011 | 60 | 0.090 |
Why?
|
| Pilot Projects | 3 | 2019 | 913 | 0.090 |
Why?
|
| Wounds and Injuries | 1 | 2012 | 228 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2016 | 635 | 0.080 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2011 | 235 | 0.080 |
Why?
|
| Pregnancy | 1 | 2016 | 2202 | 0.080 |
Why?
|
| Pancreatic Neoplasms | 1 | 2011 | 331 | 0.070 |
Why?
|
| Severity of Illness Index | 1 | 2011 | 1476 | 0.060 |
Why?
|
| Obesity | 1 | 2014 | 1165 | 0.060 |
Why?
|
| New York City | 2 | 2017 | 75 | 0.060 |
Why?
|
| Longitudinal Studies | 2 | 2020 | 1189 | 0.060 |
Why?
|
| Emergency Service, Hospital | 1 | 2012 | 1021 | 0.060 |
Why?
|
| Survival Rate | 2 | 2020 | 797 | 0.060 |
Why?
|
| Recurrence | 1 | 2024 | 599 | 0.050 |
Why?
|
| Sexism | 1 | 2023 | 29 | 0.050 |
Why?
|
| Chemoradiotherapy | 1 | 2022 | 49 | 0.050 |
Why?
|
| Accreditation | 1 | 2022 | 72 | 0.050 |
Why?
|
| Neoadjuvant Therapy | 1 | 2022 | 70 | 0.050 |
Why?
|
| Body Mass Index | 2 | 2017 | 829 | 0.050 |
Why?
|
| Pain, Postoperative | 1 | 2022 | 140 | 0.050 |
Why?
|
| Odds Ratio | 1 | 2020 | 736 | 0.040 |
Why?
|
| Analgesics, Opioid | 1 | 2022 | 482 | 0.040 |
Why?
|
| Gastroesophageal Reflux | 1 | 2018 | 81 | 0.040 |
Why?
|
| Feedback | 1 | 2017 | 87 | 0.040 |
Why?
|
| Neoplasm Grading | 1 | 2017 | 75 | 0.040 |
Why?
|
| Job Satisfaction | 1 | 2018 | 133 | 0.030 |
Why?
|
| SEER Program | 1 | 2017 | 66 | 0.030 |
Why?
|
| Registries | 1 | 2020 | 795 | 0.030 |
Why?
|
| Tertiary Care Centers | 1 | 2017 | 101 | 0.030 |
Why?
|
| Age of Onset | 1 | 2017 | 170 | 0.030 |
Why?
|
| Metabolic Syndrome | 1 | 2018 | 131 | 0.030 |
Why?
|
| Body Composition | 1 | 2017 | 146 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2017 | 485 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2016 | 205 | 0.030 |
Why?
|
| Perineum | 1 | 2016 | 19 | 0.030 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2017 | 379 | 0.030 |
Why?
|
| Abdomen | 1 | 2016 | 90 | 0.030 |
Why?
|
| Manometry | 1 | 2015 | 22 | 0.030 |
Why?
|
| Patient Compliance | 1 | 2017 | 349 | 0.030 |
Why?
|
| Adipose Tissue | 1 | 2017 | 283 | 0.030 |
Why?
|
| Postoperative Care | 1 | 2014 | 112 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 2014 | 132 | 0.030 |
Why?
|
| Wound Healing | 1 | 2014 | 172 | 0.030 |
Why?
|
| International Educational Exchange | 1 | 2012 | 2 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 2368 | 0.020 |
Why?
|
| Lymphatic Irradiation | 1 | 2011 | 2 | 0.020 |
Why?
|
| Nasal Cavity | 1 | 2011 | 10 | 0.020 |
Why?
|
| Stomatitis | 1 | 2011 | 7 | 0.020 |
Why?
|
| Radiodermatitis | 1 | 2011 | 10 | 0.020 |
Why?
|
| Radiotherapy Dosage | 1 | 2011 | 81 | 0.020 |
Why?
|
| Mouth Mucosa | 1 | 2011 | 24 | 0.020 |
Why?
|
| Deoxycytidine | 1 | 2011 | 40 | 0.020 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2011 | 39 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2011 | 185 | 0.020 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2011 | 59 | 0.020 |
Why?
|
| Depression | 1 | 2017 | 827 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2011 | 297 | 0.020 |
Why?
|
| Mutation | 1 | 2017 | 2451 | 0.020 |
Why?
|
| Child | 1 | 2011 | 4168 | 0.010 |
Why?
|